Associated Papers
Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients.
Rao VJ et al.
Journal of the American Heart Association, 2025
MYH6 Variants Are Associated with Atrial Dysfunction in Neonates with Hypoplastic Left Heart Syndrome.
Quintanilla Anfinson M et al.
Genes, 2024
Diagnostic yield after next-generation sequencing in pediatric cardiovascular disease.
Slavotinek AM et al.
Hgg Advances, 2024
Prenatal diagnosis of recurrent hypoplastic left heart syndrome associated with MYH6 variants: a case report.
Najib B et al.
Bmc Cardiovascular Disorders, 2023
Significance of α-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases.
Anfinson M et al.
Journal of Cardiovascular Development and Disease, 2022
Rare and Common Variants Uncover the Role of the Atria in Coarctation of the Aorta.
Zhu W et al.
Genes, 2022
Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
Theis JL et al.
Circulation. Genomic and Precision Medicine, 2021
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy.
Mazzarotto F et al.
Circulation, 2020
The molecular landscape of ETMR at diagnosis and relapse.
Lambo S et al.
Nature, 2019
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.
Mazzarotto F et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019
Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes.
Walsh R et al.
European Heart Journal, 2017
Impact of MYH6 variants in hypoplastic left heart syndrome.
Tomita-Mitchell A et al.
Physiological Genomics, 2016
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
Lopes LR et al.
Heart (british Cardiac Society), 2015
Heavy and light roles: myosin in the morphogenesis of the heart.
England J et al.
Cellular and Molecular Life Sciences : Cmls, 2013
Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects.
Posch MG et al.
Plos One, 2011
Alpha-cardiac myosin heavy chain (MYH6) mutations affecting myofibril formation are associated with congenital heart defects.
Granados-Riveron JT et al.
Human Molecular Genetics, 2010
Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations.
Granados-Riveron JT et al.
Congenital Heart Disease, 0